Clinical risks of St John's Wort (Hypericum perforatum) co-administration

S Soleymani, R Bahramsoltani, R Rahimi… - Expert opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: St. John's wort (SJW) is a common medicinal herb used for the
treatment of mild to moderate depression. Hyperforin, one of the chief components of SJW …

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: an overview

H Rezaee, F Pourkarim… - Pharmacology …, 2021 - Wiley Online Library
Drug‐drug interaction (DDI) is a common clinical problem that has occurred as a result of the
concomitant use of multiple drugs. DDI may occur in patients under treatment with …

Complex drug–drug–gene–disease interactions involving cytochromes P450: systematic review of published case reports and clinical perspectives

F Storelli, C Samer, JL Reny, J Desmeules… - Clinical …, 2018 - Springer
Drug pharmacokinetics (PK) is influenced by multiple intrinsic and extrinsic factors, among
which concomitant medications are responsible for drug–drug interactions (DDIs) that may …

Drug interactions and antiretroviral drug monitoring

M Foy, CJ Sperati, GM Lucas, MM Estrella - Current HIV/AIDS Reports, 2014 - Springer
Owing to the improved longevity afforded by combination antiretroviral therapy (cART), HIV-
infected individuals are developing several non-AIDS-related comorbid conditions …

[HTML][HTML] Diastereoselective Formal 1, 3-Dipolar Cycloaddition of Trifluoroethyl Amine-Derived Ketimines Enables the Desymmetrization of Cyclopentenediones

LQ Li, JQ Zhao, YP Zhang, Y You, ZH Wang, ZZ Ge… - Molecules, 2023 - mdpi.com
In this research, a metal-free diastereoselective formal 1, 3-dipolar cycloaddition of N-2, 2, 2-
trifluoroethylisatin ketimines and cyclopentene-1, 3-diones which can efficiently lead to the …

Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection

DE Karageorgopoulos, O El-Sherif… - Current opinion in …, 2014 - journals.lww.com
The drug–drug interaction studies for HCV direct-acting antivirals and antiretrovirals are
important in determining the appropriate drug combinations and dosages. The clinical …

Drug–drug interactions related to altered absorption and plasma protein binding: Theoretical and regulatory considerations, and an industry perspective

J Hochman, C Tang, T Prueksaritanont - Journal of pharmaceutical …, 2015 - Elsevier
Drug–drug interactions (DDIs) related to altered drug absorption and plasma protein binding
have received much less attention from regulatory agencies relative to DDIs mediated via …

Anti-Hepatitis C Virus (HCV) and Cytotoxic Activity of Sofosbuvir Decorated Dextran Stabilized Silver Nanoparticles

AN Awan, R Khalid, A Javed, MR Shah, SA Ali - Plasmonics, 2023 - Springer
Sofosbuvir has demonstrated several advantages over the traditional anti-hepatitis C (HCV)
therapies; however, it has been found susceptible to hydrolysis and has a risk of hepatic …

Review of drug interactions with telaprevir and antiretrovirals

RPG Van Heeswijk, M Beumont… - Antiviral …, 2013 - journals.sagepub.com
HCV infection is a major cause of mortality worldwide. HCV-related deaths also represent a
leading cause of mortality in HIV-coinfected individuals. Telaprevir is an NS3/4A protease …

Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection

LS Wu, JE Rower, JR Burton Jr… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Ribavirin, a guanosine analog, is a broad-spectrum antiviral agent. Ribavirin has been a
fundamental component of the treatment of hepatitis C virus (HCV) infection for decades, but …